Adherence to Oral Chemotherapy treatment
Research type
Research Study
Full title
What factors (including patient beliefs about medication) influence adherence to oral chemotherapy treatment among colorectal cancer patients in socially deprived locations, as compared to more affluent areas in the South East Wales region.
IRAS ID
260079
Contact name
Jane Hopkinson
Contact email
Sponsor organisation
Cardiff University
Duration of Study in the UK
0 years, 9 months, 2 days
Research summary
\nCancer treatment is a priority for the Welsh government (Welsh Assembly Government, 2004). The growing demand for cancer services and the current resource constraints demand reconfiguration of services. One solution is to move cancer treatment closer to home, which is also remit of the Velindre Transforming Cancer Services Programme (Velindre NHS, 2016). This is, in part being enabled by the development of oral chemotherapy agents but also patient preference for home treatment. \n\nThe study aim is to understand the factors (including patient beliefs) that influence adherence to oral chemotherapy treatment among colorectal cancer patients in socially deprived locations, as compared to more affluent areas in the South East Wales region. This exploratory study will utilise a case study design and will recruit participants at Velindre University NHS Trust. Within this case study design, the study will use qualitative and quantitative data collection methods to develop a deep understanding and retain a holistic perspective. As part of the data collection, the methods used will include questionnaire surveys (n= 90), observation of patient medication reviews (n= 15-20) and semi-structured interviews with patients (n= 25-30). The outcomes of this research can be used to generate empirically based recommendations for patients’ treated with oral chemotherapy medication and can inform definitive interventions for improving adherence. It will enhance the current research knowledge on oral chemotherapy treatment and inform future educational tools to support in preventing non-adherence to oral chemotherapy medication. \n\nThis study is being funded by Knowledge Economy Skills Scholarships (KESS2) and Tenovus Cancer care.
REC name
North of Scotland Research Ethics Committee 1
REC reference
19/NS/0121
Date of REC Opinion
3 Jul 2019
REC opinion
Favourable Opinion